These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32670785)

  • 21. Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity.
    Troyer BS; Kovacic Scherrer N; Garavaglia J
    J Pharm Pract; 2024 Jun; 37(3):632-636. PubMed ID: 36803310
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
    Gyanwali P; Sharma S; Pant S; Koirala P; Adhikari K; Koirala J; Dhimal M
    J Nepal Health Res Counc; 2020 Sep; 18(2):151-158. PubMed ID: 32969369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.
    Millán-Oñate J; Millan W; Mendoza LA; Sánchez CG; Fernandez-Suarez H; Bonilla-Aldana DK; Rodríguez-Morales AJ
    Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):16. PubMed ID: 32331519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality comparision in patients receiving either Remdesivir or Remdesivir plus Baricitinib combination in case of moderate to severe COVID-19 Pneumonia: A retrospective study.
    Das D; Mukhopadhyay P; Banerjee D
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
    Gonzales-Zamora JA; Quiroz T; Vega AD
    Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
    Kojima Y; Nakakubo S; Kamada K; Yamashita Y; Takei N; Nakamura J; Matsumoto M; Horii H; Sato K; Shima H; Suzuki M; Konno S
    J Med Virol; 2022 Dec; 94(12):5702-5712. PubMed ID: 35916111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia. A Multidisciplinary Perspective.
    Roshkovan L; Chatterjee N; Galperin-Aizenberg M; Gupta N; Shah R; Barbosa EM; Simpson S; Cook T; Nachiappan A; Knollmann F; Litt H; Desjardins B; Jha S; Panebianco N; Baston C; Thompson JC; Katz SI
    Ann Am Thorac Soc; 2020 Nov; 17(11):1358-1365. PubMed ID: 33124905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.
    Jorgensen SCJ; Kebriaei R; Dresser LD
    Pharmacotherapy; 2020 Jul; 40(7):659-671. PubMed ID: 32446287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.
    Yang CJ; Wei YJ; Chang HL; Chang PY; Tsai CC; Chen YH; Hsueh PR
    J Microbiol Immunol Infect; 2021 Feb; 54(1):27-36. PubMed ID: 33060041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of tocilizumab in a patient with severe COVID-19 in a Teaching Hospital in Ghana: a case report.
    Hardy YO; Hutton-Mensah KA; Amenuke DAY; Amoah-Dankwah J
    Pan Afr Med J; 2020; 37(Suppl 1):30. PubMed ID: 33456654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific evidence in the COVID-19 treatment: A comprehensive review.
    Iturricastillo G; Ávalos Pérez-Urría E; Couñago F; Landete P
    World J Virol; 2021 Sep; 10(5):217-228. PubMed ID: 34631473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study.
    Falcone M; Tiseo G; Barbieri G; Galfo V; Russo A; Virdis A; Forfori F; Corradi F; Guarracino F; Carrozzi L; Celi A; Santini M; Monzani F; De Marco S; Pistello M; Danesi R; Ghiadoni L; Farcomeni A; Menichetti F;
    Open Forum Infect Dis; 2020 Dec; 7(12):ofaa563. PubMed ID: 33365358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.